CHIESI ILAC TICARETA.S.

CHIESI ILAC TICARETA.S. Company Introduction:

CHIESI ILAC TICARETA.S. is the Turkish subsidiary of the Chiesi Group, an international research-focused biopharmaceutical company. Operating in Turkey, the company is primarily responsible for the marketing, sales, and distribution of Chiesi's innovative pharmaceutical products. It focuses on several key therapeutic areas, including respiratory diseases, neonatology, rare diseases, and transplantation. The company aims to enhance the health and well-being of patients in Turkey by making advanced medical treatments available, while upholding global quality standards and ethical business practices.

Factory or Trader:

CHIESI ILAC TICARETA.S. is primarily a trader and distributor. It serves as the commercial arm for the sales, marketing, and distribution of pharmaceutical products manufactured by the global Chiesi Group. While the overarching Chiesi Group is a manufacturer of pharmaceuticals, CHIESI ILAC TICARETA.S. specifically functions as the local sales and distribution entity in Turkey, rather than operating as a manufacturing plant itself.

Here are some of the products that Chiesi İlaç Ticaret A.Ş. (Turkey) manufactures or markets:

* Pneumology: Products for respiratory diseases, such as asthma and COPD.

* Neonatology: Products for newborns, including those for respiratory distress syndrome.

* Rare Diseases: Treatments for rare and genetic disorders.

* Special Care: Products focused on specific therapeutic areas needing specialized medical attention.

* Cardiology: Products related to the heart.